161 related articles for article (PubMed ID: 7694489)
1. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats.
Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M
Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489
[TBL] [Abstract][Full Text] [Related]
2. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat.
Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H
J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864
[TBL] [Abstract][Full Text] [Related]
3. Gabexate and camostat, synthetic proteinase inhibitors, as direct inducing factors of water and bicarbonate secretion in the isolated and blood-perfused dog pancreas.
Horiuchi A; Iwatsuki K; Yonekura H; Ren LM; Chiba S
J Pharmacol Exp Ther; 1990 Jan; 252(1):320-6. PubMed ID: 1688943
[TBL] [Abstract][Full Text] [Related]
4. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
Watanabe S; Takeuchi T; Chey WY
Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
[TBL] [Abstract][Full Text] [Related]
5. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
6. CCK-, secretin-, and cholinergic-independent pancreatic fluid hypersecretion in protease inhibitor-treated rats.
Yamamoto M; Shirohara H; Otsuki M
Am J Physiol; 1998 Feb; 274(2):G406-12. PubMed ID: 9486196
[TBL] [Abstract][Full Text] [Related]
7. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
8. Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidinobenzoyloxy) phenyl] propionate methanesulfonate (TT-S24) on pancreatic secretion in rats.
Tagami H; Abe S; Yoshida Y; Tanaka I; Kamei C
Methods Find Exp Clin Pharmacol; 1998 Dec; 20(10):855-60. PubMed ID: 10091222
[TBL] [Abstract][Full Text] [Related]
9. Elevation of resting fluid secretion precedes trophic responses in the rat pancreas following a single oral administration of Camostat.
Terasawa K; Kanno T
Int J Pancreatol; 1991 Apr; 8(3):263-74. PubMed ID: 2051064
[TBL] [Abstract][Full Text] [Related]
10. Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
Jia D; Taguchi M; Otsuki M
Metabolism; 2005 May; 54(5):619-27. PubMed ID: 15877292
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic and biliary excretion of camostat in dogs.
Kitagawa M; Hayakawa T; Kondo T; Shibata T; Sugimoto Y
Digestion; 1988; 39(4):204-9. PubMed ID: 3220174
[TBL] [Abstract][Full Text] [Related]
12. Changes in pattern of enzyme secretion by rat pancreas during repeated trypsin inhibitor treatment.
Keim V; Göke B; Adler G
Am J Physiol; 1988 Aug; 255(2 Pt 1):G236-41. PubMed ID: 2457325
[TBL] [Abstract][Full Text] [Related]
13. Feedback regulation of human pancreatic secretion. Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes.
Layer P; Jansen JB; Cherian L; Lamers CB; Goebell H
Gastroenterology; 1990 May; 98(5 Pt 1):1311-9. PubMed ID: 2323522
[TBL] [Abstract][Full Text] [Related]
14. Activation of the mTOR signalling pathway is required for pancreatic growth in protease-inhibitor-fed mice.
Crozier SJ; Sans MD; Guo L; D'Alecy LG; Williams JA
J Physiol; 2006 Jun; 573(Pt 3):775-86. PubMed ID: 16613881
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats.
Yuasa C; Irimura K; Oda M; Fukui K; Oka T
J Pharm Pharmacol; 1999 Jul; 51(7):867-71. PubMed ID: 10467964
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of pancreatic amino acid transport in rats after treatment with the synthetic protease inhibitor camostat mesilate.
Mann GE; Muñoz M
Pancreas; 1989; 4(5):601-5. PubMed ID: 2813329
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral administration of protease inhibitor on pancreatic exocrine function in WBN/Kob rats with chronic pancreatitis.
Sugiyama M; Kobori O; Atomi Y; Wada N; Kuroda A; Muto T
Pancreas; 1996 Jul; 13(1):71-9. PubMed ID: 8783337
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
19. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice.
Crozier SJ; Sans MD; Lang CH; D'Alecy LG; Ernst SA; Williams JA
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1148-57. PubMed ID: 18356533
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous administration of the synthetic trypsin inhibitor Foy-305 induces hypertrophy of the exocrine pancreas.
Wereszczyńska-Siemiatkowska U; Pohl U; Otto J; Lankisch PG
Digestion; 1987; 37(3):144-8. PubMed ID: 2443410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
